Why magnesium sulfate ‘coverage’ only is not enough to reduce eclampsia: Lessons learned in a middle-income country
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Pregnancy Hypertension
- Vol. 22, 136-143
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health
This publication has 32 references indexed in Scilit:
- Eclampsia, a comparison within the International Network of Obstetric Survey SystemsBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional studyThe Lancet, 2013
- Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancyBMC Public Health, 2011
- Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia2008
- Eclampsia in the United Kingdom 2005BJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable casesActa Obstetricia et Gynecologica Scandinavica, 2006
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialThe Lancet, 2002
- Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level <90 mm Hg in association with proteinuria?American Journal of Obstetrics and Gynecology, 2000
- Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia TrialThe Lancet, 1995